Technical Analysis for MTEM - Molecular Templates, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New Uptrend | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
20 DMA Resistance | Bearish | -3.89% | |
Calm After Storm | Range Contraction | -3.89% | |
Narrow Range Bar | Range Contraction | -3.89% |
Alert | Time |
---|---|
10 DMA Resistance | about 22 hours ago |
Down 5% | about 22 hours ago |
Down 3% | about 22 hours ago |
Fell Below Previous Day's Low | about 22 hours ago |
Down 2 % | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is headquartered in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Cancer Treatment Oncology Treatment Of Cancer Chemical Elements Lymphoma Oxygen Toxins Prodrugs Evofosfamide Prodrug Nitrogen Mustards
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Cancer Treatment Oncology Treatment Of Cancer Chemical Elements Lymphoma Oxygen Toxins Prodrugs Evofosfamide Prodrug Nitrogen Mustards
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.37 |
52 Week Low | 0.295 |
Average Volume | 12,401,445 |
200-Day Moving Average | 1.62 |
50-Day Moving Average | 0.87 |
20-Day Moving Average | 0.45 |
10-Day Moving Average | 0.41 |
Average True Range | 0.13 |
RSI (14) | 39.39 |
ADX | 25.53 |
+DI | 45.94 |
-DI | 20.41 |
Chandelier Exit (Long, 3 ATRs) | 0.73 |
Chandelier Exit (Short, 3 ATRs) | 0.72 |
Upper Bollinger Bands | 0.61 |
Lower Bollinger Band | 0.28 |
Percent B (%b) | 0.33 |
BandWidth | 75.80 |
MACD Line | -0.12 |
MACD Signal Line | -0.15 |
MACD Histogram | 0.0304 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.45 | ||||
Resistance 3 (R3) | 0.45 | 0.44 | 0.44 | ||
Resistance 2 (R2) | 0.44 | 0.42 | 0.43 | 0.43 | |
Resistance 1 (R1) | 0.41 | 0.41 | 0.40 | 0.41 | 0.43 |
Pivot Point | 0.40 | 0.40 | 0.39 | 0.39 | 0.40 |
Support 1 (S1) | 0.37 | 0.38 | 0.37 | 0.37 | 0.35 |
Support 2 (S2) | 0.36 | 0.37 | 0.36 | 0.34 | |
Support 3 (S3) | 0.33 | 0.36 | 0.34 | ||
Support 4 (S4) | 0.33 |